Sustainability Report

The report presents Eurofarma's 2024 global growth and consolidated sustainability performance, including 13,300+ employees across 24 countries and R$11 billion in net revenue. It reports 21,450 tCO2e of Scope 1 emissions, 4,340 tCO2e of Scope 2 emissions and 24,303 tCO2e of Scope 3 emissions, while describing renewable-energy expansion and emissions neutralization. Social highlights include 1.7 million donated medicines, more than 21,000 people reached through education initiatives and 1,900 premature babies supported by Lactare. The disclosures cover Eurofarma's operations in Brazil and other countries and are reported in accordance with GRI Standards with limited assurance over included GRI indicators.